DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Gynecology Surgical Instruments Market by Product (Scissors, Forceps, Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), & End User (Hospital, Clinic, Ambulatory Surgery) - Global Forecast to 2021" report to their offering.
The global gynecology surgical instruments market is poised to reach USD 2.44 billion by 2021 from USD 1.73 billion in 2016, at a CAGR of 7.1% from 2016 to 2021.
Major factors contributing to the growth of the global market include a high incidence of gynecological diseases, increasing awareness on gynecological diseases, and rising government investments for providing advanced healthcare facilities & services.
North America commanded the largest share of the global market in 2016. Asia is expected to grow at the highest CAGR. The high growth in the Asian market is attributed to increasing awareness programs, high incidence of gynecological diseases, increasing number of hospitals, government initiatives focusing on women's health, and improvements in the healthcare sector of Asian countries. Some prominent markets in Asia include China, India, and Japan.
- High Incidence of Gynecological Diseases
- Government Initiatives
- Increasing Number of Gynecology Surgeries
- Increasing Awareness on Gynecological Diseases
- Reductions in Medicare Payments to Healthcare Providers in the U.S.
- Increasing Preference for Robotic Surgeries
- Emerging Asian Markets
- Free-Trade Agreements
- Dearth of Gynecologists
- B. Braun Melsungen AG
- Coopersurgical, Inc. (A Unit of the Cooper Companies, Inc.)
- Ethicon, Inc. (A Subsidiary of Johnson & Johnson)
- KLS Martin Group
- Karl Storz GmbH & Co. Kg
- Medgyn Products, Inc.
- Olympus Corporation
- Richard Wolf GmbH
- Sklar Surgical Instruments
- Tetra Surgical
For more information about this report visit http://www.researchandmarkets.com/research/6ds63j/gynecology